首页|天津市2019-2022年新报告HIV感染者抗病毒治疗前病毒载量基线特征分析

天津市2019-2022年新报告HIV感染者抗病毒治疗前病毒载量基线特征分析

扫码查看
目的 了解天津市新报告HIV感染者抗病毒治疗前病毒载量(VL)基线特征及相关因素。 方法 资料来源于中国疾病预防控制信息系统,研究对象为天津市2019-2022年新报告且首次抗病毒治疗前HIV感染者,收集其社会人口学特征、CD4+T淋巴细胞(CD4)计数及VL值等基线信息,基线高VL值定义标准为≥100 000拷贝数/ml,分析影响VL水平的相关因素。采用SPSS 24.0软件进行统计学分析。 结果 研究对象新报告HIV感染者共1 296例,其中,基线高VL值的HIV感染者占15.89%(206/1 296)。多因素logistic回归分析结果显示,有STD史者(aOR=1.45,95%CI:1.00~2.08),基线高VL值的可能性较大;相比于基线CD4计数<200个/µl者,基线CD4计数分别为200~350个/μl(aOR=0.40,95%CI:0.27~0.57)、351~500个/μl(aOR=0.32,95%CI:0.20~0.49)和>500个/µl者(aOR=0.30,95%CI:0.18~0.49)的基线高VL值的可能性较小。 结论 2019-2022年天津市HIV感染者抗病毒治疗前基线VL值高的比例较低,HIV感染者基线VL值高的相关因素为有STD史和基线CD4计数<200个/µl,艾滋病防控工作应给予重点关注。 Objective To understand the baseline viral load (VL) of newly reported HIV- infected patients before antiretroviral therapy and related factors in Tianjin. Methods Data were obtained from the China Disease Control and Prevention Information System, and the study subjects were HIV-infected patients before the first antiretroviral therapy in Tianjin from 2019 to 2022, and the information about their socio-demographic characteristics, baseline CD4+T lymphocyte (CD4) counts before antiretroviral therapy and baseline VL test results were collected, the baseline high VL was defined as ≥100 000 copies/ml. The effect of different factors on viral load were analyzed. Software SPSS 24.0 was used for statistical analysis. Results A total of 1 296 newly reported HIV-infected patients were included in the study, in whom 15.89% (206/1 296) had high baseline VL, and multifactorial logistic regression analysis showed that those with history of STD (aOR=1.45, 95%CI:1.00-2.08) were more likely to have high baseline VL. Compared with those with baseline CD4 counts <200 cells/μl, those with baseline CD4 counts 200-350 cells/μl (a OR=0.40, 95%CI: 0.27-0.57), 351-500 cells/μl (aOR=0.32, 95%CI: 0.20-0.49), and >500 cells/μl (a OR=0.30, 95%CI: 0.18-0.49) were less likely to have high baseline VL. Conclusions The proportion of HIV-infected patients with high baseline VL before antiretroviral therapy was low in Tianjin during 2019-2022. History of STD and baseline CD4 counts <200 cells/μl were associated with high baseline VL in HIV-infected patients, to which close attention needs to be paid in AIDS prevention and control.
Characteristics of baseline viral load before antiretroviral therapy in newly reported HIV-infected patients in Tianjin, 2019-2022
Objective To understand the baseline viral load (VL) of newly reported HIV- infected patients before antiretroviral therapy and related factors in Tianjin. Methods Data were obtained from the China Disease Control and Prevention Information System, and the study subjects were HIV-infected patients before the first antiretroviral therapy in Tianjin from 2019 to 2022, and the information about their socio-demographic characteristics, baseline CD4+T lymphocyte (CD4) counts before antiretroviral therapy and baseline VL test results were collected, the baseline high VL was defined as ≥100 000 copies/ml. The effect of different factors on viral load were analyzed. Software SPSS 24.0 was used for statistical analysis. Results A total of 1 296 newly reported HIV-infected patients were included in the study, in whom 15.89% (206/1 296) had high baseline VL, and multifactorial logistic regression analysis showed that those with history of STD (aOR=1.45, 95%CI:1.00-2.08) were more likely to have high baseline VL. Compared with those with baseline CD4 counts <200 cells/μl, those with baseline CD4 counts 200-350 cells/μl (a OR=0.40, 95%CI: 0.27-0.57), 351-500 cells/μl (aOR=0.32, 95%CI: 0.20-0.49), and >500 cells/μl (a OR=0.30, 95%CI: 0.18-0.49) were less likely to have high baseline VL. Conclusions The proportion of HIV-infected patients with high baseline VL before antiretroviral therapy was low in Tianjin during 2019-2022. History of STD and baseline CD4 counts <200 cells/μl were associated with high baseline VL in HIV-infected patients, to which close attention needs to be paid in AIDS prevention and control.

HIVViral loadAntiretroviral therapyBaseline

赵璇、候金余、朱静瑾、郑敏娜、李龙、宁铁林、于茂河、斗智

展开 >

天津市疾病预防控制中心/天津市传染病病原微生物重点实验室,性病艾滋病预防控制所,天津 300011

艾滋病病毒 病毒载量 抗病毒治疗 基线

天津市医学重点学科项目天津市卫生健康科研项目

TJYXZDXK-050ATJWJ2022QN094

2024

中华流行病学杂志
中华医学会

中华流行病学杂志

CSTPCD北大核心
影响因子:1.985
ISSN:0254-6450
年,卷(期):2024.45(3)
  • 17